Table 2 Proportion of patients reporting NIDL and overall combined FLIE score relative to experiencing complete response
Treatment group | CR | Â | Patients reporting NIDL | FLIE overall combined score | |||
|---|---|---|---|---|---|---|---|
Acute | Delayed | No. of patients | N | % | Mean (SD) | Median (range) | |
NEPA+DEX1 | Yes | Yes | 52 | 38 | 73.1 | 113.1 (16.6) | 118.2 (28.7–126) |
Yes | No | 13 | 2 | 15.4 | 85.6 (26.8) | 89.6 (23.6–120.5) | |
No | Yes | 0 | – | – | – | – | |
No | No | 5 | 0 | 0 | 79.1 (30.5) | 93.5 (31–102.2) | |
NEPA+DEX3 | Yes | Yes | 54 | 41 | 75.9 | 112.6 (17.8) | 118.4 (31.1–126) |
Yes | No | 10 | 3 | 30 | 88.6 (23.1) | 89.9 (46.9–115.7) | |
No | Yes | 0 | – | – | – | – | |
No | No | 7 | 0 | 0 | 98.7 (10.9) | 102.6 (74.8–105.9) | |
NEPA+DEX4 | Yes | Yes | 54 | 43 | 79.6 | 117 (8.4) | 119.2 (99–126) |
Yes | No | 10 | 3 | 30 | 91.6 (29) | 95.6 (27–124.2) | |
No | Yes | 0 | – | – | – | – | |
No | No | 7 | 2 | 28.6 | 106.2 (16.9) | 114.2 (80.1–121.1) | |